Selected research
Industry Growth & Trends
Global Taxifolin Industry Growth and Trends Forecast to 2032
Market perspective
The global Taxifolin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Taxifolin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Taxifolin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Taxifolin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Taxifolin include Ametis JSC, JW Health Products, Kalenika Group, Hefei Lifeon Pharma, ROBIOS, Kingherbs Ltd, Beton Nutrition Corporation and Xi'an Sost Biotech Co.,Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Taxifolin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Taxifolin market size, estimates, and forecasts are presented in terms of sales volume (KG) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Taxifolin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Taxifolin.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Taxifolin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Taxifolin Market by Company
Ametis JSC
JW Health Products
Kalenika Group
Hefei Lifeon Pharma
ROBIOS
Kingherbs Ltd
Beton Nutrition Corporation
Xi'an Sost Biotech Co.,Ltd
Taxifolin Segment by Type
Below 92%
92%-98%
Above 98%
Taxifolin Segment by Application
Food and Beverages
Healthcare
Cosmetics
Agriculture
Others
Taxifolin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Taxifolin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Taxifolin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Taxifolin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Taxifolin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Taxifolin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Below 92%
- 92%-98%
- Above 98%
Applications
- Food and Beverages
- Healthcare
- Cosmetics
- Agriculture
- Others
Companies covered
- Ametis JSC
- JW Health Products
- Kalenika Group
- Hefei Lifeon Pharma
- ROBIOS
- Kingherbs Ltd
- Beton Nutrition Corporation
- Xi'an Sost Biotech Co.,Ltd
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Taxifolin Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Taxifolin Sales Estimates and Forecasts (2021-2032)
- 1.3 Taxifolin Market by Type
- 1.3.1 Below 92%
- 1.3.2 92%-98%
- 1.3.3 Above 98%
- 1.4 Global Taxifolin Market Size by Type
- 1.4.1 Global Taxifolin Market Size Overview by Type (2021-2032)
- 1.4.2 Global Taxifolin Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Taxifolin Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Taxifolin Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Taxifolin Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Taxifolin Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Taxifolin Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Taxifolin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Taxifolin Industry Trends
- 2.2 Taxifolin Industry Drivers
- 2.3 Taxifolin Industry Opportunities and Challenges
- 2.4 Taxifolin Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Taxifolin Revenue (2021-2026)
- 3.2 Global Top Players by Taxifolin Sales (2021-2026)
- 3.3 Global Top Players by Taxifolin Price (2021-2026)
- 3.4 Global Taxifolin Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Taxifolin Major Company Production Sites & Headquarters
- 3.6 Global Taxifolin Company, Product Type & Application
- 3.7 Global Taxifolin Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Taxifolin Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Taxifolin Players Market Share by Revenue in 2025
- 3.8.3 2025 Taxifolin Tier 1, Tier 2, and Tier 3
4 Taxifolin Regional Status and Outlook
- 4.1 Global Taxifolin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Taxifolin Historic Market Size by Region
- 4.2.1 Global Taxifolin Sales in Volume by Region (2021-2026)
- 4.2.2 Global Taxifolin Sales in Value by Region (2021-2026)
- 4.2.3 Global Taxifolin Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Taxifolin Forecasted Market Size by Region
- 4.3.1 Global Taxifolin Sales in Volume by Region (2027-2032)
- 4.3.2 Global Taxifolin Sales in Value by Region (2027-2032)
- 4.3.3 Global Taxifolin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Taxifolin by Application
- 5.1 Taxifolin Market by Application
- 5.1.1 Food and Beverages
- 5.1.2 Healthcare
- 5.1.3 Cosmetics
- 5.1.4 Agriculture
- 5.1.5 Others
- 5.2 Global Taxifolin Market Size by Application
- 5.2.1 Global Taxifolin Market Size Overview by Application (2021-2032)
- 5.2.2 Global Taxifolin Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Taxifolin Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Taxifolin Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Taxifolin Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Taxifolin Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Taxifolin Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Taxifolin Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Ametis JSC
- 6.1.1 Ametis JSC Company Information
- 6.1.2 Ametis JSC Business Overview
- 6.1.3 Ametis JSC Taxifolin Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Ametis JSC Taxifolin Product Portfolio
- 6.1.5 Ametis JSC Recent Developments
- 6.2 JW Health Products
- 6.2.1 JW Health Products Company Information
- 6.2.2 JW Health Products Business Overview
- 6.2.3 JW Health Products Taxifolin Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 JW Health Products Taxifolin Product Portfolio
- 6.2.5 JW Health Products Recent Developments
- 6.3 Kalenika Group
- 6.3.1 Kalenika Group Company Information
- 6.3.2 Kalenika Group Business Overview
- 6.3.3 Kalenika Group Taxifolin Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Kalenika Group Taxifolin Product Portfolio
- 6.3.5 Kalenika Group Recent Developments
- 6.4 Hefei Lifeon Pharma
- 6.4.1 Hefei Lifeon Pharma Company Information
- 6.4.2 Hefei Lifeon Pharma Business Overview
- 6.4.3 Hefei Lifeon Pharma Taxifolin Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Hefei Lifeon Pharma Taxifolin Product Portfolio
- 6.4.5 Hefei Lifeon Pharma Recent Developments
- 6.5 ROBIOS
- 6.5.1 ROBIOS Company Information
- 6.5.2 ROBIOS Business Overview
- 6.5.3 ROBIOS Taxifolin Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 ROBIOS Taxifolin Product Portfolio
- 6.5.5 ROBIOS Recent Developments
- 6.6 Kingherbs Ltd
- 6.6.1 Kingherbs Ltd Company Information
- 6.6.2 Kingherbs Ltd Business Overview
- 6.6.3 Kingherbs Ltd Taxifolin Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Kingherbs Ltd Taxifolin Product Portfolio
- 6.6.5 Kingherbs Ltd Recent Developments
- 6.7 Beton Nutrition Corporation
- 6.7.1 Beton Nutrition Corporation Company Information
- 6.7.2 Beton Nutrition Corporation Business Overview
- 6.7.3 Beton Nutrition Corporation Taxifolin Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Beton Nutrition Corporation Taxifolin Product Portfolio
- 6.7.5 Beton Nutrition Corporation Recent Developments
- 6.8 Xi'an Sost Biotech Co.,Ltd
- 6.8.1 Xi'an Sost Biotech Co.,Ltd Company Information
- 6.8.2 Xi'an Sost Biotech Co.,Ltd Business Overview
- 6.8.3 Xi'an Sost Biotech Co.,Ltd Taxifolin Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Xi'an Sost Biotech Co.,Ltd Taxifolin Product Portfolio
- 6.8.5 Xi'an Sost Biotech Co.,Ltd Recent Developments
7 North America by Country
- 7.1 North America Taxifolin Sales by Country
- 7.1.1 North America Taxifolin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Taxifolin Sales by Country (2021-2026)
- 7.1.3 North America Taxifolin Sales Forecast by Country (2027-2032)
- 7.2 North America Taxifolin Market Size by Country
- 7.2.1 North America Taxifolin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Taxifolin Market Size by Country (2021-2026)
- 7.2.3 North America Taxifolin Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Taxifolin Sales by Country
- 8.1.1 Europe Taxifolin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Taxifolin Sales by Country (2021-2026)
- 8.1.3 Europe Taxifolin Sales Forecast by Country (2027-2032)
- 8.2 Europe Taxifolin Market Size by Country
- 8.2.1 Europe Taxifolin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Taxifolin Market Size by Country (2021-2026)
- 8.2.3 Europe Taxifolin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Taxifolin Sales by Country
- 9.1.1 Asia-Pacific Taxifolin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Taxifolin Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Taxifolin Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Taxifolin Market Size by Country
- 9.2.1 Asia-Pacific Taxifolin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Taxifolin Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Taxifolin Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Taxifolin Sales by Country
- 10.1.1 South America Taxifolin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Taxifolin Sales by Country (2021-2026)
- 10.1.3 South America Taxifolin Sales Forecast by Country (2027-2032)
- 10.2 South America Taxifolin Market Size by Country
- 10.2.1 South America Taxifolin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Taxifolin Market Size by Country (2021-2026)
- 10.2.3 South America Taxifolin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Taxifolin Sales by Country
- 11.1.1 Middle East and Africa Taxifolin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Taxifolin Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Taxifolin Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Taxifolin Market Size by Country
- 11.2.1 Middle East and Africa Taxifolin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Taxifolin Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Taxifolin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Taxifolin Value Chain Analysis
- 12.1.1 Taxifolin Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Taxifolin Production Mode & Process
- 12.2 Taxifolin Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Taxifolin Distributors
- 12.2.3 Taxifolin Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst